News Overview

Shares of Kaynes Technology India were currently trading at Rs 704.30, representing a premium of 19.98% as compared with the issue price of Rs 587.

This simulator will help the Urologist and patient to understand treatment of infertility and andrology more efficiently.

The company stated that it is confident that with his international market experience and track record of driving customer excellence, Lance will maintain Mercedes-growth Benz's momentum in India.

As of now, the National Monetization Pipeline (NMP) has allowed the government to monetize assets worth Rs 33,422 crore, with the Coal Ministry topping the list with Rs 17,000 crore

The platform has a high level of localization and was created by Bajaj Auto specifically for Yulu Bikes with the latter's technology inputs.

The public issue is priced at a price band of Rs559 per share to Rs587 per share respectively having a face value of Rs10 each.

Glenmark Pharmaceuticals rose 1.32% to Rs 417 after the drug maker and its US arm, Glenmark Pharmaceuticals Inc. have reached a settlement agreement with Pfizer Inc., PF Prism C.V., and PF Prism IMB B.V. (Pfizer) for Axitinib Tablets.

Lender asserts to be the first company in GIFT City to provide these products

Glenmark had previously announced that the United States Food and Drug Administration (USFDA) had tentatively approved their generic Axitinib Tablets.

The Delhivery share post-IPO lock-in period of six months came to an end on November 20